CatalystMarker
← board

KTTAW

distress 4/10 · elevated risk
$0.01-10%today-10% from 52w high
pasithea.com5 employeesFounded 2020Miami Beach, FL
Revenue
pre-revenue
Liquidity
$50M
Runway
3.0 yrs
Shares 1y
+349%

Price & events

-3.9% over 6M
$0.01$0.01$0.01Mar 26May 26Jul 26880
CatalystRating changeDilutionFinancingdashed = today
-10.1%
1D
+40.0%
1W
-10.1%
1M
-10.1%
3M
—
6M
—
1Y
—
2Y
—
5Y
-3.9%
All

Overview

Market Cap
$327.46K
Volume
880
52 Week Range
$0.01 – $0.01
Total Shares
33.41M
Float Shares
16.62M
RVOL
18.97x
Beta
0.29

Pipeline · 0 trials · 0 upcoming

ReadoutPhaseDrugIndicationEnrollStatus
No pipeline trials tracked.

Catalyst news & presentations · 0

  • No catalyst news yet.

Approved drugs (0)

  • none — clinical-stage

Capital structure — dilution & financing

Shares out: 33,414,448 · 1 offerings/1y · 1 PIPEs
  • 2026-01-27EFFECTshelf_effective
  • 2025-12-028-Kprivate_placement
  • 2025-12-01424B4offering
  • 2025-11-28EFFECTshelf_effective
  • 2025-11-26S-1/Ashelf_registration
  • 2025-11-18S-1shelf_registration
  • 2025-06-20424B5offering
🔒 Positioning — Pro
Short interest / days-to-cover, insider buys & sells.
Upgrade to Pro
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to Pro

Wall St ratings

no consensus
  • no recent rating changes

Competitors

  • none identified

Recent news

  • none

Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.